A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HCC / hepatocarcinoma

[Related PubMed/MEDLINE]
Total Number of Papers: 132
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HCC  (>> Co-occurring Abbreviation)
Long Form:   hepatocarcinoma
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Factors Affecting Local and Intra Hepatic Distant Recurrence After Surgery for Hcc: An Alternative Perspective on Microvascular Invasion and Satellitosis - A Western European Multicentre Study. DR, LR
2020 Is It Just a Matter of Surgical Extension to Achieve the Cure of Hepatocarcinoma? A Meta-Analysis of Propensity-Matched and Randomized Studies for Anatomic Versus Parenchyma-Sparing Liver Resection. DFS, MVI, OS, PSR, RCT
2020 Naturally Occurring and Engineered Alphaviruses Sensitive to Double-Stranded-RNA-Activated Protein Kinase Show Restricted Translation in Mammalian Cells, Increased Sensitivity to Interferon, and Marked Oncotropism. AURAV, DLP, dsRNA, IFN, IFNs, PKR, SV
2020 Treatment of hepatocarcinoma beyond the milan criteria. A weighted comparative study of surgical resection versus chemoembolization. DFS, IPW, MC, OS, SR, TACE
2019 A comparison between radiofrequency ablation combined with transarterial chemoembolization and surgical resection in hepatic carcinoma: A meta-analysis. CI, DFS, OS, RFA, RR, SR, TACE
2019 Antitumor Effects of Quercetin in Hepatocarcinoma In Vitro and In Vivo Models: A Systematic Review. WoS
2019 Chemical and Pharmacological Aspects of Caffeic Acid and Its Activity in Hepatocarcinoma. CA, ROS
2019 Construction and analysis of a comprehensive protein interaction network of HCV with its host Homo sapiens. ---
2019 Curcumin Suppresses Hepatic Stellate Cell-Induced Hepatocarcinoma Angiogenesis and Invasion through Downregulating CTGF. CTGF, EMT, HIF-1alpha, HSCs, IL-6, Nrf2, ROS, SDF-1, VEGF
10  2019 Designing pH-triggered drug release iron oxide nanocomposites for MRI-guided photothermal-chemoembolization therapy of liver orthotopic cancer. DOX, IA, MRI, NIR, PDA
11  2019 Ganoderic acid loaded nano-lipidic carriers improvise treatment of hepatocellular carcinoma. DEN, GA
12  2019 Histone deacetylase 2 regulates the doxorubicin (Dox) resistance of hepatocarcinoma cells and transcription of ABCB1. DOX, HDACs
13  2019 Plant seed protease inhibitors differentially affect innate immunity in a tumor microenvironment to control hepatocarcinoma. STPIs
14  2019 Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells. BNIP3, HIFs
15  2019 The ALPPS procedure: hepatocellular carcinoma as a main indication. An Italian single-center experience. CC, CRLM, DFS, FLR, MCCLM, MVI
16  2019 The impact of age and ageing on hepatocarcinoma surgery: Short- and long-term outcomes in a multicentre propensity-matched cohort. OR, OS, PYLL, RFS, TSS
17  2019 The prognostic role of liver stiffness in patients with chronic liver disease: a systematic review and dose-response meta-analysis. CIs, CLDs, Glst, HD, LREs, LS, LSM, RRs, TE
18  2019 Thioredoxin Downregulation Enhances Sorafenib Effects in Hepatocarcinoma Cells. MAPK, STAT3
19  2018 Acetylated Polyethylenimine-Entrapped Gold Nanoparticles Enable Negative Computed Tomography Imaging of Orthotopic Hepatic Carcinoma. CT, FI, PEI
20  2018 alpha-1,3-Fucosyltransferase-VII siRNA inhibits the expression of SLex and hepatocarcinoma cell proliferation. FUT, PLCgamma, si, SLex
21  2018 Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathways. AnxA5, LN, LNM
22  2018 Biochemical Evidence for the Antitumor Potential of Garcinia mangostana Linn. On Diethylnitrosamine-Induced Hepatic Carcinoma. AFP, CEA, DEN
23  2018 Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells. CGA, MAPK, mTOR, PI3K
24  2018 Chronic liver injury promotes hepatocarcinoma cell seeding and growth, associated with infiltration by macrophages. HL
25  2018 Diethylnitrosamine Increases Proliferation in Early Stages of Hepatic Carcinogenesis in Insulin-Treated Type 1 Diabetic Mice. DEN, T1DM, VEGF
26  2018 Hepatic peroxisome proliferator-activated receptor gamma coactivator 1beta drives mitochondrial and anabolic signatures that contribute to hepatocellular carcinoma progression in mice. PPARgamma, ROS
27  2018 How Rap and its GEFs control liver physiology and cancer development. C3G alterations in human hepatocarcinoma. ---
28  2018 Long non-coding RNA linc-ITGB1 promotes cell proliferation, migration, and invasion in human hepatoma carcinoma by up-regulating ROCK1. lncRNA, ROC, ROCK1
29  2018 Metformin Enhances the Effect of Regorafenib and Inhibits Recurrence and Metastasis of Hepatic Carcinoma After Liver Resection via Regulating Expression of Hypoxia Inducible Factors 2alpha (HIF-2alpha) and 30 kDa HIV Tat-Interacting Protein (TIP30). HIF, HIF-2alpha, MTF, NLK, RGF
30  2018 Novel GPC3-binding WS2-Ga3+-PEG-peptide nanosheets for in vivo bimodal imaging-guided photothermal therapy. ---
31  2018 Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3beta/beta-catenin signalling. CSCs, PCR, PI3K, SGK3
32  2018 Recurrence Patterns After Anatomic or Parenchyma-Sparing Liver Resection for Hepatocarcinoma in a Western Population of Cirrhotic Patients. AR, DFS, PSA, PSR
33  2018 Wogonin Suppresses the Activity of Matrix Metalloproteinase-9 and Inhibits Migration and Invasion in Human Hepatocellular Carcinoma. MMP-9
34  2018 [Biejiajian Pills inhibits hepatoma carcinoma cell vasculogenic mimicry by suppressing RhoA/ROCK signaling pathway]. VM
35  2017 Farnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives. ARS, DHA, FTS, NAC, PS, ROS
36  2017 G2/M checkpoint plays a vital role at the early stage of HCC by analysis of key pathways and genes. DEGs, GSEA, IPA, RMA
37  2017 Involvement of PI3K/Akt pathway in the inhibition of hepatocarcinoma cell invasion and metastasis induced by SASH1 through downregulating Shh-Gli1 signaling. ---
38  2017 Long-term Administration of Nuclear Bile Acid Receptor FXR Agonist Prevents Spontaneous Hepatocarcinogenesis in Abcb4-/- Mice. BA, FXR
39  2017 miR-146a negatively regulates NK cell functions via STAT1 signaling. CHB, IFN, IL, miR, NK
40  2017 PLGA-based dual targeted nanoparticles enhance miRNA transfection efficiency in hepatic carcinoma. Lip2000, miR-99a, NPs
41  2017 Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers. CCA, DEN, T-UCR
42  2016 An HBV-tolerant immunocompetent model that effectively simulates chronic hepatitis B virus infection in mice. HBV, HDI, RNAi
43  2016 Antitumor Effect of the Mannich Base(1,3-bis-((3-Hydroxynaphthalen-2-yl)phenylmethyl)urea) on Hepatocellular Carcinoma. 1,3-BPMU, DEN
44  2016 Cortactin and Exo70 mediated invasion of hepatoma carcinoma cells by MMP-9 secretion. CTTN, MMP-9
45  2016 Differential Antitumoral Properties and Renal-Associated Tissue Damage Induced by Tacrolimus and Mammalian Target of Rapamycin Inhibitors in Hepatocarcinoma: In Vitro and In Vivo Studies. OLT
46  2016 High expression of hexokinase domain containing 1 is associated with poor prognosis and aggressive phenotype in hepatocarcinoma. AFP, HKDC1, OS
47  2016 Influence of Toxoplasma gondii on invitro proliferation and apoptosis of hepatoma carcinoma H7402 cell. T. gondii
48  2016 Innate immunity and hepatocarcinoma: Can toll-like receptors open the door to oncogenesis? TLR
49  2016 LncRNA CRNDE promotes hepatic carcinoma cell proliferation, migration and invasion by suppressing miR-384. CRNDE, PCR
50  2016 Loss of MYC and E-box3 binding contributes to defective MYC-mediated transcriptional suppression of human MC-let-7a-1~let-7d in glioblastoma. ChIP, GBM
51  2016 Phenotypic Characterization Analysis of Human Hepatocarcinoma by Urine Metabolomics Approach. ---
52  2016 Valproic acid (VPA) promotes the epithelial mesenchymal transition of hepatocarcinoma cells via transcriptional and post-transcriptional up regulation of Snail. EMT, VPA
53  2016 [Diagnostic value of liver imaging reporting and data system MRI on primary hepatocellular carcinoma]. ACR, LI-RADS
54  2015 Ceramide metabolism regulates autophagy and apoptotic cell death induced by melatonin in liver cancer cells. ASMase, SPT
55  2015 Dual Inhibition of Cdc7 and Cdk9 by PHA-767491 Suppresses Hepatocarcinoma Synergistically with 5-Fluorouracil. 5-FU, Cdc7, CDK9, Chk1
56  2015 Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases. CHC, HCV
57  2014 Activation of phosphatidylinositol 3-kinase/Akt signaling mediates sorafenib-induced invasion and metastasis in hepatocellular carcinoma. EMT, PI3K, RT-PCR
58  2014 Bio-responsive chitin-poly(L-lactic acid) composite nanogels for liver cancer. DOX
59  2014 Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease? IGF, NAFLD, PPAR
60  2014 Cumulative HIV viremia and non-AIDS-defining malignancies among a sample of HIV-infected male veterans. aHR, CI, HL, NADMs, SCCA
61  2014 Dysregulation of the TGFBI gene is involved in the oncogenic activity of the nonsense mutation of hepatitis B virus surface gene sW182*. GSEA, HBV, TGFBI
62  2014 Galactosylated polymeric carriers for liver targeting of sorafenib. PLA
63  2014 MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1alpha. HIF-1
64  2014 Treatment of spontaneous ruptured hepatocellular carcinoma: A single-center study. TAE
65  2014 [The synergism and mechanism of action of rClone30-hDR5 in combination with TRAIL on HCC]. ---
66  2013 Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients? HE, TK
67  2013 How did chronic hepatitis C impact costs related to hospital health care in France in 2009? CHC, CIR, LT
68  2013 Potential applications of miRNAs as diagnostic and prognostic markers in liver cancer. miRNAs
69  2013 Ruptured hepatic carcinoma after transcatheter arterial chemoembolization. TACE
70  2013 Surgical resection for small hepatocellular carcinoma in cirrhosis: the Eastern experience. ---
71  2013 Urinary metabolic profiling identifies a key role for glycocholic acid in human liver cancer by ultra-performance liquid-chromatography coupled with high-definition mass spectrometry. UPLC-Q-TOF-HDMS
72  2012 Cerebral lipiodol embolism after transarterial chemoembolization for hepatic carcinoma: a case report. CLE, TACE
73  2012 Increasing the donor pool reduces the severity of liver disease: lessons learned from Sao Paulo, Brazil. MELD
74  2012 N-acetylcysteine improves antitumoural response of Interferon alpha by NF-kB downregulation in liver cancer cells. IFN, NAC, NF-kB
75  2012 Pravastatin inhibits cell proliferation and increased MAT1A expression in hepatocarcinoma cells and in vivo models. ---
76  2012 Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells. ---
77  2012 [The clinical pathway of treatment of hepatocellular carcinoma]. CUN
78  2011 Characterization of woodchuck apolipoprotein A-I: a new tool for drug delivery and identification of altered isoforms in the woodchuck chronic hepatitis model. apoA-I, HDL, ORF, WHV
79  2011 Identification of serum biomarkers of hepatocarcinoma through liquid chromatography/mass spectrometry-based metabonomic method. AFP, LC/MS
80  2011 Microwave thermal ablation for hepatocarcinoma: six liver transplantation cases. CT, HBV, HCV, MELD, MWA, RFA
81  2011 Structural and functional studies of the human selenium binding protein-1 and its involvement in hepatocellular carcinoma. SELENBP1
82  2011 Targeting cell death and survival receptors in hepatocellular carcinoma. DR, TNFR, TRAIL
83  2011 The performance of gadolinium diethylene triamine pentaacetate-pullulan hepatocyte-specific T1 contrast agent for MRI. MR, MRI
84  2011 [Downregulation of chromobox protein homolog 7 expression in multiple human cancer tissues]. cbx7, CRC, GC, ROC
85  2010 Gas chromatography/time-of-flight mass spectrometry-based metabonomics of hepatocarcinoma in rats with lung metastasis: elucidation of the metabolic characteristics of hepatocarcinoma at formation and metastasis. DEN, GC/TOFMS, HLM, PLS-DA, TCA
86  2010 Polyploidization of liver cells. ---
87  2010 Stimulation of B7-H1 in hepatocarcinoma cells by hepatitis B virus X antigen. HBx, qPCR
88  2010 Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment. HCV, NO, ROS
89  2009 S6K1 deficiency protects against apoptosis in hepatocytes. ERK, IRS-1, mTOR, PI3K, TNF-alpha
90  2009 The Ras inhibitor farnesylthiosalicyclic acid (FTS) prevents nodule formation and development of preneoplastic foci of altered hepatocytes in rats. DEN, FTS
91  2008 Laparoscopic liver resection for hepatocellular carcinoma. ---
92  2008 Natural course of chronic HCV and HBV infection and role of alcohol in the general population: the Dionysos Study. FL, HBV, HCV, LC, PY, RR
93  2008 New cellular tools reveal complex epithelial-mesenchymal interactions in hepatocarcinogenesis. MF
94  2008 Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric alpha-fetoprotein promoter. AFP, E. coli, MeP-dR, PNP
95  2008 [Influence of donor age and recipient gender on survival in transplantation due to hepatocarcinoma]. ---
96  2008 [Risks factors for pediatric malignant liver tumors]. B1AF, BW, HB, HBV, IHS, PHMs, RFs
97  2007 Changes in the antioxidant system by TNP-470 in an in vivo model of hepatocarcinoma. CAT, GPx
98  2007 In vitro transfection of the hepatitis B virus PreS2 gene into the human hepatocarcinoma cell line HepG2 induces upregulation of human telomerase reverse transcriptase. HBV, hTERT
99  2006 Gemcitabine and liposomal doxorubicin in biliary and hepatic carcinoma (HCC) chemotherapy: preliminary results and review of the literature. LD
100  2006 Insulin-like growth factor-I stimulates H4II rat hepatoma cell proliferation: dominant role of PI-3'K/Akt signaling. PI-3'K